Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-002002
Filing Date
2015-01-13
Accepted
2015-01-13 15:55:08
Documents
1
Period of Report
2014-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 v396437_4.html 4  
1 FORM 4 v396437_4.xml 4 4381
  Complete submission text file 0001144204-15-002002.txt   6056
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 855 N. WOLFE STREET, SUITE 619 BALTIMORE MD 21205
Business Address
Morris Ronnie (Reporting) CIK: 0001504443 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17263 | Film No.: 15524781